{
    "id": 26874,
    "fullName": "PIK3CA V955I",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA V955I lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). V955I results in activation of Pik3ca signaling as indicated by increased phosphorylation of Akt and Mapk3/Mapk1 (Erk1/2), and confers resistance to Erbitux (cetuximab) in culture (PMID: 28424201) and therefore, is predicted to result in a gain of Pik3ca protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "V955I",
    "createDate": "08/16/2017",
    "updateDate": "09/14/2018",
    "referenceTranscriptCoordinates": {
        "id": 172275,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179230303G>A",
        "cDna": "c.2863G>A",
        "protein": "p.V955I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11719,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, PIK3CA V955I was identified as a potential mechanism for acquired Erbitux (cetuximab) resistance in a colorectal cancer patient, which is supported by cell culture studies demonstrating resistance to Erbitux (cetuximab) and Fluorouracil combination treatment in colorectal cancer cells over expressing PIK3CA V955I (PMID: 28424201).",
            "molecularProfile": {
                "id": 28198,
                "profileName": "PIK3CA V955I"
            },
            "therapy": {
                "id": 2000,
                "therapyName": "Cetuximab + Fluorouracil",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9728,
                    "pubMedId": 28424201,
                    "title": "PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28424201"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28198,
            "profileName": "PIK3CA V955I",
            "profileTreatmentApproaches": [
                {
                    "id": 17520,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17524,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17522,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17519,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17523,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17521,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17526,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA V955I"
                },
                {
                    "id": 17525,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA V955I"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 172276,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179230303G>A",
            "cDna": "c.2863G>A",
            "protein": "p.V955I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172275,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179230303G>A",
            "cDna": "c.2863G>A",
            "protein": "p.V955I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 172274,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179230303G>A",
            "cDna": "c.2863G>A",
            "protein": "p.V955I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}